The first COVAX shipment of 348,000 doses of AstraZeneca’s Covishield vaccine arrived safely in Kathmandu, Nepal’s capital, before being distributed to provinces and municipalities throughout the world.
The vaccines, which were manufactured by the Serum Institute of India (SII), as well as 350,000 syringes and 3,500 vaccine safety boxes, arrived in Kathmandu on March 7, making Nepal one of the first countries in Asia to receive COVID-19 vaccines from the COVAX Facility, which will aid the government’s efforts to vaccinate some of Nepal’s most vulnerable population.
Vaccines funded by COVAX are an important part of the Government of Nepal’s National Deployment and Vaccination Plan (NDVP), which aims to vaccinate approximately 22 million people, including refugees, migrant returnees, and other migrant populations. Nepal was able to start the vaccination campaign thanks to the generous contribution of the Indian government, and 429,705 people have been vaccinated to date. Members of the WHO Nepal team, such as driver Laxmi Thapa Magar, are critical in reaching vulnerable people in Nepal’s remote provinces.
WHO
In Colorado,Bear Spotted Relaxing in Children’s Backyard Pool
Macedonian Shepherd Dog – Karaman
AI-Powered Web Application Firewalls (WAFs) Security Solution
Chinese Police Arrest Uyghur Sisters and Mother in Urumqi for Sending Goods to Turkey
UN Secretary-General Addresses World Artificial Intelligence Conference Meteorological Forum
At Tidal Flats,Seal Pup Found with Gunshot Wound to its Head
Transylvanian First Romanian Origin Cat Breed
